ADC Therapeutics SA (ADCT) Return on equity
ADC Therapeutics SA (ADCT) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-197.8%FY2022
| Fiscal year | Value | YoY |
|---|---|---|
| FY2022 | -197.8% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More ADCT financial trends
ADCT RevenueADCT Net incomeADCT Net marginADCT Gross profitADCT Gross marginADCT Operating incomeADCT Operating marginADCT Operating cash flowADCT Free cash flowADCT Capital expendituresADCT Stock buybacksADCT Dividends paidADCT Total assetsADCT Total liabilitiesADCT Shareholders’ equityADCT overview →